Thekla von dem Berge

Author

Kinderkrankenhaus auf der Bult ORCID

Also Known As

T von dem Berge, T. von dem Berge, Thekla Berge, Thekla von dem Berge, Torben Biester, von dem Berge, Thekla

Publications

703

Citations

H-Index

Concepts

All Affiliations

Kinderkrankenhaus auf der Bult Klinikum rechts der Isar Ljubljana University Medical Centre KU Leuven Technische Universität Dresden

About

Thekla von dem Berge is an author at Kinderkrankenhaus auf der Bult specializing in diabetes, pediatrics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	148
2	Engineering	1	1	234
3	Health Sciences	1	1	50
4	Public Health	1	1	55
5	Data Science	1	1	234

Thekla von dem Berge

Publications

614

Citations

H-Index

Page 1

	Year	Citations
Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes Revital Nimri, Tadej Battelino, Lori M. Laffel, Nature Medicine Artificial IntelligenceType 1Diabetes ManagementEngineeringData Science	2020	234
Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The <scp>DAPADream</scp> study Torben Biester, Ido Muller, Thekla von dem Berge, Diabetes Obesity and Metabolism	2020	57
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results Christiane Winkler, Florian Haupt, Martin Heigermoser, Pediatric Diabetes Family MedicineGenetic TestingGenetic EpidemiologyIncreased Type 1Clinical Genetics	2019	55
Elevations in blood glucose before and after the appearance of islet autoantibodies in children Katharina Warncke, Peter Achenbach, Thekla von dem Berge, Journal of Clinical Investigation Genetic EpidemiologyImmunologyIslet AutoantibodiesInsulin SignalingMetabolic Syndrome	2022	50
Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry Clemens Kamrath, Sascha R. Tittel, Thomas Kapellen, The Lancet Child & Adolescent Health Family MedicineType 1Diabetes ManagementInsulin ManagementDiabetes	2020	43
Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial Tadej Battelino, Ramin Tehranchi, Timothy S. Bailey, Pediatric Diabetes	2021	35
In‐home use of a hybrid closed loop achieves time‐in‐range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial Thekla von dem Berge, K Remus, Sarah Biester, Diabetes Obesity and Metabolism	2022	34
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood Marija Lugar, Anne Eugster, Peter Achenbach, JAMA	2023	31
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes Emile Hendriks, M. Loredana Marcovecchio, Rachel Besser, Diabetes/Metabolism Research and Reviews	2024	26
A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670G Stuart A. Weinzimer, Ryan Bailey, Richard M. Bergenstal, Diabetes Technology & Therapeutics	2022	19

Page 1